Lung disease features in Brazilian children with HIV infection before HAART era

Journal of Tropical Pediatrics

Volumn 52, Issue 5, 2006, Pages 360-368

  Toro, A A D C ^a   Altemani, A A M ^a   Zanardi, V A ^a   Menezes, J R ^a   da Silva, M N ^a   Vilela, Maria Marluce S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL PNEUMONIA; BRAZIL; CHILD CARE; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMAGE ANALYSIS; INFANT; INTERSTITIAL PNEUMONIA; LONGITUDINAL STUDY; LUNG BIOPSY; LUNG DIFFUSION; LUNG DISEASE; LUNG TUBERCULOSIS; LYMPHADENOPATHY; LYMPHOID HYPERPLASIA; MEDICAL RECORD; MONOTHERAPY; MORBIDITY; MYCOBACTERIUM TUBERCULOSIS; PNEUMONIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; RISK FACTOR; THORAX RADIOGRAPHY; VERTICAL TRANSMISSION;

ANTI-RETROVIRAL AGENTS; BRAZIL; CHILD; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; HYPERPLASIA; LONGITUDINAL STUDIES; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPHOID TISSUE; MALE; NECROSIS; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS;

EID: 33749590941     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fml019     Document Type: Article

References (41)

1. Agostini C, Trentin L, Zambello R, et al. State of the Art: HIV-1 and the lung. Am Rev Resp Dis 1993;147:1038-49.
2. Andiman WA, Shearer WT. Lymphoid interstitial pneumonitis. In: Pizzo PA, Wilfert MC (eds), Pediatric AIDS, 3rd edn. Baltimore, Williams & Wilkins, 1998; 117-25.
3. Quinn TC, Ruff A, Halsey N. Pediatric acquired immunodeficiency syndrome: Special consideration for developing nations. Pediatr Infect Dis J 1992; 11(7):558-68.
4. Hauger SB. Approach to the pediatric patient with HIV infection and pulmonary symptoms. J Pediatr 1991;119(1):S25-S33.
5. Beck JM, Rosen MJ, Peavy HH. Report of the Fourth NHLBI Workshop Pulmonary Complications of HIV Infection. Am J Respir Crit Care Med 2001;164(11):2120-26.
6. Webb WR. High resolution lung computed tomography: Normal anatomic and pathologic findings. Radiol Clin North Am 1991;29(5):1051-63.
7. Joshii VV. Pathologic Findings associated with HIV infection in children. In: Pizzo PA, Wilfert CM (eds), Pediatric AIDS, Williams and Wilkins, Baltimore, 1991;125.
8. Miller CR. Pediatric aspects of AIDS. Radiol Clin North Am 1997;35(5):1191-21.
9. Anderson VM, Lee H. Lymphocytic interstitial pneumonitis in pediatric AIDS. Pediatric Pathol 1988;8:417-21.
10. Thaker HK, Snow MH. HIV suppression in the era of antiretroviral therapy. Postgrad Med J 2003;79:36-42.
11. Centers For Disease Control And Prevention (1994). Revised classification system for HIV-1 infection in children less than 13 years of age. Morb Mortal Weekly Rep 1994;43(RR-12):1-10.
12. CDC. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR 1991; 40(No. RR-2):1-13.
13. Revised Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Children Infected with or Perinatally Exposed to Human Immunodeficiency Virus. MMWR 1995;44(RR-4): 1-11.
14. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Pediatr Infect Dis 1993;12(6):513-22.
15. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. MMWR 1998; 47(RR-4):1-31.
16. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type-1 infection. N Engl J Med 1989;321:1791-96.
17. Blanche S, Tardieu M, Duliege A, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection: Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child 1990;144: 1210-15.
18. Farley JJ, King JC, Nair P, et al. Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection. J Pediatr 1994;124:853-58.
19. Wilfert MC. Invasive bacterial infections in children with HIV infection. In: Pizzo PA, Wilfert MC (eds), Pediatrics AIDS, 3a Edition Williams & Wilkins, Baltimore, 1998;117-125.
20. Roilides E, Butler KM, Husson RN, et al. Pseudomonas infections in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1992;11(7):547-553.
21. Sorvillo F, Beall G, Turner PA, et al. Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: Association with hospital exposure. Am J Infect Control 2001;29(2):79-84.
22. Paiva MA, Reis FJC, Fisher GB, et al. Pneumonias na Criança. I Consenso Brasileiro de Pneumonias. J Pneumologia 1998;24(2):1001-1108.
23. Nascimento-Carvalho CM, Souza-Marques HH. Recommendation of the Brazilian Society of Pediatrics for antibiotic therapy in children and adolescents with community-acquired pneumonia. Rev Panam Salud Publica 2004;15(6):380-7:1020-4989.
24. Hortal M, Ruvinsky R, Rossi A, et al. Impact of Streptococcus pneumoniae on pneumonia in Latin American children. SIREVA-Vigia Group Rev Panam Salud Publica 2000;8(3):185-95.
25. Nascimento-Carvalho CM. Etiology of childhood community acquired pneumonia and its implications for vaccination. Braz J Infect Dis 2001;5(2):87-97.
26. Madhi SA, Kuwanda L, Cutland C, et al. Quantitative and Qualitative Antibody Response to Pneumococcal Conjugate Vaccine Among African Human Immunodeficiency Virus-Infected and Uninfected Children. Pediatr Infect Dis J 2005;24(5):410-16.
27. Kale KL, King Jr JC, Farley JJ, et al. The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants. Pediatr Infect Dis J 1995;14:350-4.
28. Madhi SA, Petersen K, Khoosal M, et al. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 2002;21:315-21.
29. Rutstein RM, Rudy BJ, Cnaan A. Response of human immunodeficiency virus-exposed and infected infants to Haemophilus influenzae type b conjugate vaccine. Arch Pediatr Adolesc Med 1996;150(8):838-41.
30. De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004;103(6):2180-86.
31. Saloojee H, Violari A. Regular review: HIV infection in children. BMJ 2001;323:670-74.
32. Perez Mato S, Van Dyke RB. Pulmonary infections in children with HIV infection. Semin Respir Infect 2002;17(1):33-46.
33. Graham SM. Impact of HIV on childhood respiratory illness: Differences between developing and developed countries. Pediatric Pulmology 2003;36:462-68.
34. Simonds RJ, Oxtoby MJ, Caldwell MB, et al. Pneumocystis carinii pneumonia among U.S. children with perinatally acquired HIV infection. JAMA 1993; 270:470-3.
35. Norton KI, Kattan M, Rao IS, et al. Chronic radiographic lung changes in children with vertically transmitted HIV-1 infection. A J R Am J Roentgenol 2001;176(6):1553-8.
36. Andiman WA, Martin K, Rubinstein A, et al. Opportunistic lymphoproliferations associated with Epstein -Barr viral DNA in infants and children with AIDS. Lancet 1985;2:1390-93.
37. Katz BZ, Berkman AB, Shapiro ED. Serologic evidence of active Epstein -Barr virus -associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. J Pediatr 1992;120:228-32.
38. Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: A narrative review. Chest 2002;122:2150-64.
39. Kabra SK, Lodha R, Seth V. Some current concepts on childhood tuberculosis. Indian J Med Res 2004; 120:387-97.
40. Feldman C. Pneumonia associated with HIV infection. Current Opinion in Infectious Diseases 2005;18: 165-70.
41. Pizzo PA, Wilfert CM. Markers and determinant of disease progression in children with HIV infection. The pediatric AIDS Siena Workshop II. J Acquir Immune Defic Syndr 1995;1(8):30-44.